LINE1-mediated epigenetic repression of androgen receptor transcription causes androgen insensitivity syndrome

Jelena Pozojevic,Radhika Sivaprasad,Joshua Laß,Franziska Haarich,Joanne Trinh,Naseebullah Kakar,Kristin Schulz,Kristian Händler,Annemarie A Verrijn Stuart,Jacques C Giltay,Koen L van Gassen,Almuth Caliebe,Paul-Martin Holterhus,Malte Spielmann,Nadine C Hornig
DOI: https://doi.org/10.1038/s41598-024-65439-w
2024-07-15
Abstract:Androgen insensitivity syndrome (AIS) is a difference of sex development (DSD) characterized by different degrees of undervirilization in individuals with a 46,XY karyotype despite normal to high gonadal testosterone production. Classically, AIS is explained by hemizygous mutations in the X-chromosomal androgen receptor (AR) gene. Nevertheless, the majority of individuals with clinically diagnosed AIS do not carry an AR gene mutation. Here, we present a patient with a 46,XY karyotype, born with undervirilized genitalia, age-appropriate testosterone levels and no uterus, characteristic for AIS. Diagnostic whole exome sequencing (WES) showed a maternally inherited LINE1 (L1) retrotransposon insertion in the 5' untranslated region (5'UTR) of the AR gene. Long-read nanopore sequencing confirmed this as an insertion of a truncated L1 element of ≈ 2.7 kb and showed an increased DNA methylation at the L1 insertion site in patient-derived genital skin fibroblasts (GSFs) compared to healthy controls. The insertion coincided with reduced AR transcript and protein levels in patient-derived GSFs confirming the clinical diagnosis AIS. Our results underline the relevance of retrotransposons in human disease, and expand the growing list of human diseases associated with them.
What problem does this paper attempt to address?